Clinical Studies

Advanced Endoscopy

Diabetes RElated to Acute pancreatitis and its Mechanisms (DREAM)

Prinicpal Investigator: Guru Trikudanathan

Currently Recruiting

Description: The purpose of this research study is to find out how many people with acute pancreatitis develop diabetes. Risk factors for diabetes and the types of diabetes that occur after acute pancreatitis will also be studied.

Learn more about this study at Study Finder

Luminal

Real-Time Feedback (RTFB) to Improve Colonoscopy

Prinicpal Investigator: Piet de Groen

Currently Recruiting

Learn more about this study on Study Finder

RPC01-3202: Induction Study #2 - A phase 3, multicenter, randomized, double-blind, placebo-controlled study of oral ozanimod as induction therapy for moderately to severely active crohn’s disease

Prinicpal Investigator: Eugenia Shmidt

Currently Recruiting

Description: This is a Phase 3, randomized, double-blind, placebo-controlled study to determine the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active CD, defined as a CDAI score ≥ 220 to ≤ 450.

Learn more about this study on Study Finder

UP0085: A postmarketing, multicenter, longitudinal, prospective, pharmacokinetic, phase 1B study in pregnant women with chronic inflammatory diseases treated with cimzia (certolizumab pegol)

Prinicpal Investigator: Eugenia Shmidt

Currently Recruiting

Description: A postmarketing, multicenter, longitudinal, prospective, pharmacokinetic, phase 1B study in pregnant women with chronic inflammatory diseases treated with cimzia

Learn more about this study on Study Finder

A novel Peptamen-based enteral nutrition protocol for treatment of Crohn s disease A Pilot Trial

Prinicpal Investigator: Byron Vaughn

Currently Recruiting

Description: The purpose of this study is to evaluate the therapeutic feasibility of a Peptamen-based, oral nutrition dietary regimen for treatment of adult Crohn’s disease. Specifically we are evaluating if consuming 80-100% of caloric needs from Peptamen 1.5 for 4 weeks is feasible for the potential future use therapeutically in adult Crohn’s disease.

Learn more about this study on Study Finder

RCT01437: Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn s disease: The OPTIMIZE Trial

Prinicpal Investigator: Byron Vaughn

Currently Recruiting

Description: The purpose of this study is to find out if using a computer program (called iDose) to guide infliximab dosing is more effective and safer than using standard infliximab dosing over 52 weeks.

Learn more about this study on Study Finder

Fecal Microbiota Transplant for Postoperative Crohn's Disease

Prinicpal Investigator: Byron Vaughn

Currently Recruiting

Description: People with Crohn's disease often need surgery. The gut bacteria of people with Crohn's is associated with Crohn's disease coming back after surgery. Fecal microbiota transplant (FMT) after surgery might be a way to prevent Crohn's disease from coming back after surgery. This study aims to determine if fecal microbiota transplant (FMT) taken by capsules results in the same amount of good bacteria in the guts as FMT by colonoscopy in people with Crohn's disease who have had surgery.

Learn more about this study on Study Finder

Low sulfur fecal transplant for ulcerative colitis

Prinicpal Investigator: Byron Vaughn

Currently Recruiting

Description: This study is a pilot randomized controlled clinical trial examining how fecal microbiota transplant (FMT) given by capsules can change the bacteria and inflammation in people with active ulcerative colitis (UC). We will look at global changes of bacterial composition while on FMT versus those not on FMT.

Learn more about this study on Study Finder

Corrona Inflammatory Bowel Disease (IBD) Registry

Prinicpal Investigator: Byron Vaughn

Currently Recruiting

Description: This is a prospective, non-interventional, research study for patients with IBD under the care of a certified gastroenterologist. The primary objective for this registry is to prospectively study the natural history of IBD, the prevalence and incidence of comorbidities, targeted adverse events, and more, via questionnaires.

Learn more about this study on Study Finder

Microbiota Therapeutics Program

The Microbiota Therapeutics Program is active in actively recruiting patients for clinical trials related to Leukemia, Ulcerative Colitis, and more. Go to the UMN Microbiota Therapeutics Program website for more information.

Hepatology

Evaluation of the Safety and Efficacy of DUR-928 for Alcohol Relative Hepatitis - AHFIRM

Principal Investigator: Julie Thompson

Currently Recruiting

Description: A multicenter study evaluating the safety and impact of DUR-928 on outcomes for adult patients with alcohol related hepatitis.

Learn more about this study at study at ClinicalTrials.gov

ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement

Prinicpal Investigator: Nicholas Lim

Currently Recruiting

Description: ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement.

Learn more about this study at ClinicalTrials.gov

StudyFinder is a University of Minnesota website that displays a searchable listing of studies, which are extracted from ClinicalTrials.gov. At StudyFinder you can explore University health studies currently seeking participants.

Clinicaltrials.gov is a database of privately and publicly funded clinical studies conducted around the world.